Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract

盐酸噻氯匹定/银杏叶提取物

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NameTiclopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract
Drug Alias NameYuclid
ClassificationSmall molecules
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsEmbolism and ThrombosisArterial Occlusive DiseasesCarotid Stenosis +[4] 
Global Approved IndicationsEmbolism and ThrombosisArterial Occlusive DiseasesCerebrovascular Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2008/04/04
Country/TerritorySouth Korea
CombinationsYes Ticlopidine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesYuyu Pharma. Inc
China Registration ClassN/A

Develop Information

Active CompaniesYuyu Pharma. Inc
Inactive CompaniesN/A
Active IndicationsEmbolism and ThrombosisArterial Occlusive DiseasesCerebrovascular Disorders
Inactive IndicationsCarotid Stenosis

Other Information

ATC CodeN/A
Related LinksN/A